A 23-year-old male with a history of posterior urethral valves complicated by chronic kidney disease requiring renal transplantation at age 19 was incidentally found to have extensive gingival overgrowth on physical examination ( Figs. 1 and 2 ). The gingival overgrowth developed several months after the patient's transplant and progressively worsened. His medications had included mycophenolate mofetil, tacrolimus, and amlodipine since his renal transplant 4 years prior.
A 23-year-old male with a history of posterior urethral valves complicated by chronic kidney disease requiring renal transplantation at age 19 was incidentally found to have extensive gingival overgrowth on physical examination ( Figs. 1 and 2 ). The gingival overgrowth developed several months after the patient's transplant and progressively worsened. His medications had included mycophenolate mofetil, tacrolimus, and amlodipine since his renal transplant 4 years prior.
Medications other than anticonvulsants and cyclosporine can cause gingival overgrowth.
1 This patient's gingival overgrowth was attributed to the combination of amlodipine and tacrolimus. Limited studies have demonstrated low rates of gingival overgrowth with tacrolimus, 1 with prevalence ranging from 0% to 29%. However, the incidence increases with concomitant use of calcium channel blockers and in those with poor oral hygiene. 2 As single agents, calcium channel blockers have also rarely been reported to induce gingival overgrowth. 1 Proper oral hygiene can help prevent progression, but will not reverse gingival overgrowth. Treatment options include discontinuation of causative medications and gingivectomy, although recurrence rates with this procedure are as high as 40%. 
